Modalities prostate cancer diagnostic imaging. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Neoplastic Cells, Circulating Stromal Cells

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Transgenic

Diseases36

Neoplasms Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Adenocarcinoma Neoplasm Metastasis Disease Progression Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Lung Neoplasms Carcinoma Neoplasm Recurrence, Local Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Stomach Neoplasms Pancreatic Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Prostatitis Urinary Bladder Neoplasms Colorectal Neoplasms Neovascularization, Pathologic Disease Models, Animal Uterine Cervical Neoplasms Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating Rectal Neoplasms Radiation Injuries Liver Neoplasms Erectile Dysfunction Endometrial Neoplasms

Chemicals and Drugs67

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Tosyl Compounds Antineoplastic Agents Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists Anilides RNA, Messenger Dihydrotestosterone Finasteride Metribolone RNA, Small Interfering Flutamide Cancer Vaccines Anticarcinogenic Agents Glutamate Carboxypeptidase II Taxoids DNA, Neoplasm 5-alpha Reductase Inhibitors PTEN Phosphohydrolase Antigens, Neoplasm Testosterone Congeners Antineoplastic Agents, Phytogenic Testosterone Androstenols 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Nitriles Azasteroids Phenylthiohydantoin Proto-Oncogene Proteins c-akt RNA, Neoplasm Racemases and Epimerases Tumor Suppressor Protein p53 MicroRNAs Transcription Factors Cholestenone 5 alpha-Reductase Tumor Suppressor Proteins Antibodies, Monoclonal Radiopharmaceuticals Estramustine Leuprolide Receptor, erbB-2 Goserelin Glutathione S-Transferase pi Receptors, Estrogen DNA-Binding Proteins DNA Primers Proto-Oncogene Proteins Enzyme Inhibitors Proto-Oncogene Proteins c-bcl-2 Kallikreins Paclitaxel Biological Markers Prostatic Secretory Proteins Oncogene Proteins, Fusion Androgen-Binding Protein Steroid 17-alpha-Hydroxylase Ki-67 Antigen Insulin-Like Growth Factor Binding Protein 3 Reagent Kits, Diagnostic Receptor, Epidermal Growth Factor Carotenoids Nuclear Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment85

Prostatectomy Orchiectomy Early Detection of Cancer Sensitivity and Specificity Neoplasm Staging Prognosis Neoplasm Grading Risk Factors Reverse Transcriptase Polymerase Chain Reaction Combined Modality Therapy Retrospective Studies Xenograft Model Antitumor Assays Prospective Studies Digital Rectal Examination Biopsy Neoplasm Transplantation Immunohistochemistry Follow-Up Studies Case-Control Studies Treatment Outcome Predictive Value of Tests Transplantation, Heterologous Reproducibility of Results Diagnostic Imaging Gene Expression Profiling Blotting, Western Biopsy, Needle Risk Assessment Risk Survival Rate Transurethral Resection of Prostate Survival Analysis Cohort Studies Incidence Odds Ratio Polymerase Chain Reaction Diagnostic Errors Brachytherapy Oligonucleotide Array Sequence Analysis Tumor Burden ROC Curve Tomography, X-Ray Computed Disease-Free Survival Transfection Multivariate Analysis Radiotherapy Tissue Array Analysis Antineoplastic Combined Chemotherapy Protocols Registries Questionnaires Logistic Models SEER Program Castration Radiotherapy Dosage Magnetic Resonance Imaging Mass Screening Diagnostic Tests, Routine Kaplan-Meier Estimate Molecular Targeted Therapy Radiotherapy, Conformal Nomograms Diagnostic Techniques and Procedures Drug Screening Assays, Antitumor Models, Biological Immunoenzyme Techniques Positron-Emission Tomography Confidence Intervals Disease Models, Animal Clinical Trials as Topic Flow Cytometry Gene Knockdown Techniques In Situ Hybridization, Fluorescence Enzyme-Linked Immunosorbent Assay Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Chemotherapy, Adjuvant Real-Time Polymerase Chain Reaction Immunotherapy Genetic Therapy Feasibility Studies Proportional Hazards Models Radiotherapy, Image-Guided Reagent Kits, Diagnostic Pilot Projects Early Diagnosis

Psychiatry and Psychology2

Smoking Erectile Dysfunction

Phenomena and Processes43

Gene Expression Regulation, Neoplastic Sensitivity and Specificity Cell Proliferation Apoptosis Genetic Predisposition to Disease Risk Signal Transduction Time Factors Cell Growth Processes Drug Resistance, Neoplasm Genotype Down-Regulation Cell Survival Cell Division Odds Ratio Cell Movement DNA Methylation Transfection Up-Regulation Mutation Promoter Regions, Genetic Polymorphism, Genetic Cell Cycle Dose-Response Relationship, Drug Nomograms Gene Silencing Gene Fusion Base Sequence RNA Interference Genes, Tumor Suppressor Chromosomes, Human, Pair 8 Gene Expression Phosphorylation Polymorphism, Single Nucleotide Diet Algorithms Alleles Phenotype Transcription, Genetic Genes, Neoplasm Germ-Line Mutation Drug Synergism Radiation Tolerance

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Registries Questionnaires SEER Program Radiotherapy, Conformal Base Sequence Molecular Sequence Data Algorithms Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care37

Patient Navigation Sensitivity and Specificity Risk Factors Retrospective Studies Prospective Studies Watchful Waiting Follow-Up Studies Case-Control Studies Treatment Outcome Predictive Value of Tests Reproducibility of Results Risk Assessment Risk Survival Rate Survival Analysis Cohort Studies Incidence Odds Ratio Diagnostic Errors Age Factors ROC Curve Disease-Free Survival Multivariate Analysis Registries Questionnaires Logistic Models SEER Program National Cancer Institute (U.S.)Mass Screening Kaplan-Meier Estimate Nomograms Confidence Intervals Clinical Trials as Topic Feasibility Studies Radiation Injuries Proportional Hazards Models Pilot Projects

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Patient Navigation Prostate Neoplasms Prostatic Neoplasms Prostate-Specific Antigen Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Prostatectomy Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Orchiectomy Neoplasms, Hormone-Dependent Early Detection of Cancer Tumor Markers, Biological Sensitivity and Specificity Adenocarcinoma Neoplasm Metastasis Disease Progression Mice, Nude Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Staging Tosyl Compounds Neoplasm Invasiveness Prognosis Neoplasm Grading Cell Proliferation Antineoplastic Agents Tumor Cells, Cultured Risk Factors Apoptosis Antineoplastic Agents, Hormonal Genetic Predisposition to Disease Reverse Transcriptase Polymerase Chain Reaction Combined Modality Therapy Neoplasm Proteins Androgen Receptor Antagonists Retrospective Studies Xenograft Model Antitumor Assays Prospective Studies Breast Neoplasms Digital Rectal Examination Biopsy Anilides RNA, Messenger Neoplasm Transplantation Immunohistochemistry Watchful Waiting Follow-Up Studies Case-Control Studies Treatment Outcome Predictive Value of Tests Transplantation, Heterologous Reproducibility of Results Dihydrotestosterone Lung Neoplasms Finasteride Diagnostic Imaging Gene Expression Profiling Carcinoma Blotting, Western Biopsy, Needle Risk Assessment Neoplasm Recurrence, Local Risk Survival Rate United States Transurethral Resection of Prostate Survival Analysis Signal Transduction Metribolone Ovarian Neoplasms Time Factors Cell Growth Processes Drug Resistance, Neoplasm RNA, Small Interfering Genotype Prostatic Neoplasms, Castration-Resistant Cohort Studies Flutamide Incidence Down-Regulation Cancer Vaccines Anticarcinogenic Agents Cell Survival Colonic Neoplasms Cell Division Odds Ratio Glutamate Carboxypeptidase II Taxoids Mice, SCID Polymerase Chain Reaction Diagnostic Errors Brachytherapy DNA, Neoplasm 5-alpha Reductase Inhibitors Oligonucleotide Array Sequence Analysis Stomach Neoplasms

No FAQ available that match "modalities prostate cancer diagnostic imaging"